Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Biochim Biophys Acta. 2017 Jul 15;1864(4 Pt B):1220–1231. doi: 10.1016/j.bbadis.2017.06.024

Table 1.

Classification of cholangiopathies.

Genetic
  Alagille's syndrome
  Caroli's syndrome
  Cystic fibrosis
  MDR3 deficiency
  Polycystic liver disease (ADPLD, ADPKD, ARPKD)
Immune-mediated
  Acute allograft rejection
  Chronic allograft rejection
  Graft versus host disease
  Primary biliary cholangitis
Idiopathic
  Biliary atresia
  Idiopathic childhood/adulthood ductopenia
  IgG4 cholangiopathy
  Primary sclerosing cholangitis
  Sarcoidosis
Infectious
  AIDS cholangiopathy (e.g., viral cholangitis)
  Bacterial cholangitis (e.g., Escherichia coli, Klebsiella, Enterococcus, Enterobacter, Pseudomonas, anaerobes)
  Parasitic cholangitis (e.g., Ascaris lumbricoides, Opisthorchis viverrini, Clonorchis sinensis, Fasciola hepatica)
Malignant
  Cholangiocarcinoma
Other
  Drug-induced (e.g., Floxuridine-induced cholangiopathy, ketamine cholangiopathy)
  Vascular/ischemic (e.g., post-liver transplant hepatic artery stenosis, systemic vasculitis)

Abbreviations: ADPKD, autosomal dominant polycystic kidney disease; ADPLD, autosomal dominant polycystic liver disease; AIDS, acquired immunodeficiency syndrome; ARPKD, autosomal recessive polycystic kidney disease; IgG4, immunoglobulin G subclass 4; MDR3, multidrug resistance 3.